Optimized electrolyte solution for cardiac defibrillation
This technology is a specially formulated electrolyte solution with lower sodium and calibrated calcium concentrations designed to be administered to patients experiencing cardiac arrest or life-threatening arrhythmias before or during defibrillation. The idea is that the ionic environment in the heart affects how well electrical shocks work, and tuning that environment with this solution may improve the odds of successful resuscitation. The patent covers both the formulation itself and its use alongside defibrillators or pacemakers as a combination therapeutic approach.
What you could build
A pre-mixed electrolyte solution packaged for emergency or hospital use alongside defibrillation equipment, targeting hospital emergency departments, cardiac catheterization labs, and potentially EMS systems seeking to improve resuscitation outcomes.
Who in Virginia should care
Inova Health System, VCU Health, and defense medical research programs (USAMRIID, DHA) in Virginia would have interest given cardiac emergency care and combat casualty resuscitation applications.
Readiness: Lab validated
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- STEVEN POELZING, DAVID RYAN KING
- Granted
- June 1, 2021
- Status
- Granted patent
- Patent number
- 11020426
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.